Decision and Details
Board of DirectorsChanges in Reportable Segments
The three businesses have been consolidated under 日本予防医薬株式会社 as a result of the business reorganization, and the Company has transitioned to an integrated business operating structure. The business portfolio was reviewed to build a comprehensive healthcare platform and to more appropriately reflect the business activities of each reportable segment.
| Item | Details |
|---|---|
| Matter Covered | Changes in Reportable Segments |
| Decision-Making Body | Board of Directors |
| Decision Date | 12 August 2026 |
| Implementation Date | Beginning with the announcement of financial results for the first quarter of the fiscal year ending June 2027 (planned) |
| Period Covered | From the first quarter of the fiscal year ending June 2027 onward |
| Quantity / scale | The five existing reportable segments will be changed to four. The three businesses of dietary supplements, cosmetics and functional materials development will be integrated. |
| Reason | The three businesses have been consolidated under 日本予防医薬株式会社 as a result of the business reorganization, and the Company has transitioned to an integrated business operating structure. The business portfolio was reviewed to build a comprehensive healthcare platform and to more appropriately reflect the business activities of each reportable segment. |
| Future plans | Beginning with the announcement of financial results for the first quarter of the fiscal year ending June 2027, the Company will report under the new reportable segments. The new business areas are scheduled to be expanded sequentially in the future. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The three businesses have been consolidated under 日本予防医薬株式会社 as a result of the business reorganization, and the Company has transitioned to an integrated business operating structure. In addition, the business portfolio was reviewed to build a comprehensive healthcare platform and to more appropriately reflect the business activities of each reportable segment.